Japan to consider "economic security" in 7-Eleven parent takeoverJapan will look at the "economic security" aspects of any foreign acquisition of 7-Eleven, a government minister said ... |
La seconde partie du film « Godzilla », TOKYO GODZILLAs, sera diffusé…-- Reconnu par le Guinness World Records™ pour « TOKYO Night & Light »... |
Shkreli says Wu-Tang Clan should have say in lawsuit over one-off alb…Martin Shkreli argues members of the Wu-Tang Clan should be forced into a... |
Expert Sets $1 Target For Dogecoin Once It Breaks A Multi-Year Trend …Dogecoin faced a wave of selling pressure yesterday, marking a sharp 14... |
Expert Sets $1 Target For Dogecoin Once It Breaks A Multi-Year Trend …Dogecoin faced a wave of selling pressure yesterday, marking a sharp 14... |
Expert Sets $1 Target For Dogecoin Once It Breaks A Multi-Year Trend …Dogecoin faced a wave of selling pressure yesterday, marking a sharp 14... |
Expert Sets $1 Target For Dogecoin Once It Breaks A Multi-Year Trend …Dogecoin faced a wave of selling pressure yesterday, marking a sharp 14... |
Expert Sets $1 Target For Dogecoin Once It Breaks A Multi-Year Trend …Dogecoin faced a wave of selling pressure yesterday, marking a sharp 14... |
Prime 1 Studio Presents: Street Fighter 6 Juri 1/4 Scale Statue – Inc…Prime 1 Studio proudly introduces the latest addition to its Premium... |
Press Release: New Sarclisa subcutaneous formulation met co-primary e…New Sarclisa subcutaneous formulation met co-primary endpoints in the... |
Elliptic Labs Launches Two AI Virtual Smart Sensors on the ThinkPad™ …Elliptic Labs (OSE: ELABS), the global leader in AI Virtual Smart Sensors™... |
Press Release: New Sarclisa subcutaneous formulation met co-primary e…Press Release: New Sarclisa subcutaneous formulation met co-primary... |
Press Release: New Sarclisa subcutaneous formulation met co-primary e…Press Release: New Sarclisa subcutaneous formulation met co-primary... |
AS Tallinna Sadam operational volumes for Q4 and 2024 full yearAS Tallinna Sadam operational volumes for Q4 and 2024 full year In 2024 Q4... |
Communiqué de presse : La nouvelle formulation sous-cutanée du Sarcli…Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a... |
Start of Day MessageStart of Day Message LONDON, 09 Jan. 2025 (GLOBE NEWSWIRE) -- This is the... |
Thomas Kamm Appointed as Partner and Head of Communications at Antin …Regulatory News: Antin Infrastructure Partners (Paris:ANTIN) announces the... |
Press Release: New Sarclisa subcutaneous formulation met co-primary e…Press Release: New Sarclisa subcutaneous formulation met co-primary... |
Communiqué de presse : La nouvelle formulation sous-cutanée du Sarcli…Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a... |
Communiqué de presse : La nouvelle formulation sous-cutanée du Sarcli…Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions